Tagresults

Sanofi, has entered into an agreement to acquire Vicebio, a privately held biotechnology company headquartered in London, UK.

Sofinnova Partners (Sofinnova), a European life sciences venture capital firm based in Paris, London, and Milan, announced the final close of Sofinnova Biovelocita II.

Brown Foods, a Y Combinator-backed foodtech startup based in Boston, has launched world’s first lab-made whole cow milk.

Diag-Nose.io has closed oversubscribed $2 million round seed round to transform the management of chronic respiratory diseases with AI.

Nintx (Next Innovative Therapeutics), a biotech startup researching and developing treatments for multifactorial diseases using Brazil’s biodiversity, has raised additional $10 million funding.

Celleste Bio, an early-stage cocoa-tech startup, has closed of $4.5 million seed financing round to scale production of cell cultured cocoa.

Sartorius Stedim Biotech, a player in the biopharmaceutical industry, has opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

Phytolon, an Israeli biotech / food tech startup that produces natural food colors using precision fermentation, secured an undisclosed investment from Rich Products Ventures (RPV), the corporate venture capital fund of food company Rich Products (Rich's), to help drive commercialization of its innovative, sustainable and clean-label solution for natural food colorings.

Activation Capital has announced the launch of Start-the-Journey, a new Biohealth pre-accelerator designed to equip early-stage biotech and life science entrepreneurs with the knowledge and tools to build successful startups.

SOLASTA Bio, a Glasgow-based agri-biotech company specialising in the next generation of green insecticides, has raised $14 million Series A financing led by Forbion, a global life sciences venture capital firm with deep expertise in Europe.

Activation Capital, an innovation ecosystem development organization, has announced the selection of 10 fast-growing startups for the inaugural Frontier BioHealth program.

Plonts, the maker of new category of plant-based cheeses, has debuted its first product, an aged plant-based cheddar, at select restaurants in New York City and the San Francisco Bay Area, after raising a $12 million seed round and opening a pilot plant in Oakland, California.

Onego Bio, a precision fermentation company, has secured €14 million funding from the European Innovation Council (EIC) Accelerator Program and additional Series A investors.

Formation Bio, a tech-driven and AI-native pharma company, has raised $372 million Series D financing. The financing was led by a16z with significant participation from Sanofi. Current investors also joined the round, including Sequoia, Thrive, Emerson Collective, and Lachy Groom, along with new investors, such as SV Angel Growth and FPV Ventures.

J.P. Morgan Private Capital, a venture capital and growth equity investment team within J.P. Morgan Asset Management, announced the final close of the first Life Sciences Private Capital offering, 270 Life Sciences Private Capital Fund I (The Fund), led by Chief Investment Officer, Stephen Squinto and Managing Partner, Gaurav Gupta.

NSG BioLabs, Singapore-based provider of biotech co-working laboratory and office space, has announced a new partnership with Eppendorf, an international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, to support biotech startups by providing needed resources such as product and applications expertise and its networks to advance startup research and development (R&D).

Activation Capital has launched Frontier BioHealth, an educational and support program designed to provide highly specialized training, targeted mentorship and relationship building to help scale pharmaceutical, biotech, medical device, and health-focused consumer products companies.

Biotechnology startup Pandorum Technologies, has announced the closure of $11 million pre-Series B funding round.

The Google for Startups Growth Academy: AI for Health has unveiled its 2023 cohort, spotlighting 30 transformative startups from across Europe, Middle East, and Africa.

The funds raised will support the continued development of its lead drug candidate, Obefazimod, as a treatment for ulcerative colitis and other chronic inflammatory diseases